Pantoprazol Vir (Pantoprazole)

Pantoprazol Vir is a proton pump inhibitor that acts on the acid‑secretion pathway in the stomach.

• Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

• Pantoprazole inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the parietal cell surface, leading to a prolonged reduction in gastric acid secretion. This action raises gastric pH, creating an environment that allows damaged mucosa to heal and reduces irritation caused by acid exposure.

Pantoprazol Vir may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild, transient headache.
• Diarrhea: loose stools that usually resolve without treatment.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: mild discomfort in the stomach area.
• Flatulence: increased gas production.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Severe allergic reaction: rash, itching, swelling, dizziness, or trouble breathing.
• Clostridioides difficile infection: persistent watery diarrhea, abdominal cramping.\n- Low magnesium levels: muscle cramps, irregular heartbeat, seizures.
• Bone fractures: increased risk of hip, wrist, or spine fractures with long‑term use.
• Acute interstitial nephritis: kidney inflammation presenting with fever, rash, and urinary changes.

When prescribing Pantoprazol Vir, clinicians should consider several safety aspects.

• Assess renal function: adjust use in severe renal impairment.
• Monitor magnesium: long‑term therapy may lower serum magnesium.
• Evaluate bone health: prolonged use may affect calcium absorption.
• Review concomitant medications: potential for altered absorption of drugs requiring acidic pH.
• Pregnancy and lactation: use only if clearly needed.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazol Vir can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

• Ketoconazole: reduced absorption due to increased gastric pH.
• Atazanavir: markedly decreased plasma concentrations.
• Warfarin: potential increase in INR, requiring closer monitoring.

Moderate Interactions (Monitor Closely)

• Digoxin: may increase serum levels.
• Methotrexate: reduced clearance, especially at high doses.
• Iron supplements: decreased absorption; separate dosing by at least 2 hours.
• Mycophenolate mofetil: lowered exposure, may require dose adjustment.